I dont think so you can tell people are over it and they will take say 90 cents and that would be a pinch for this company and it would be a shame as the long term upside is huge.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
